News coverage about Merge Healthcare (NASDAQ:MRGE) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Merge Healthcare earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 45.4370227706985 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Merge Healthcare (NASDAQ MRGE) remained flat at $0.58 during trading on Friday. Merge Healthcare has a 52 week low of $0.50 and a 52 week high of $2.07. The company’s market cap is $179.91 million. The firm has a 50-day moving average of $7.10 and a 200-day moving average of $5.64.

TRADEMARK VIOLATION NOTICE: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Merge Healthcare (MRGE) Stock Price” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at

Merge Healthcare Company Profile

Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. The Company operates through two segments: Merge Healthcare and Merge DNA. The Company’s Merge Healthcare segment markets, sells and implements interoperability, imaging and clinical solutions to healthcare providers.

Insider Buying and Selling by Quarter for Merge Healthcare (NASDAQ:MRGE)

Receive News & Stock Ratings for Merge Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merge Healthcare Inc. and related stocks with our FREE daily email newsletter.